Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated: April 2, 2026, 3:59 am
Author: Getaka|Social: XLinkedIn
Stock Ticker - BSE: 543499 | NSE: ACHYUT

Achyut Healthcare Ltd: Intrinsic Value & Share Price Analysis

Fair Value

₹5.96Fairly Valued by 6.05%vs CMP ₹5.62

P/E (308.0) × ROE (1.8%) × BV (₹1.34) × DY (2.00%)

₹1.86Overvalued by 66.90%vs CMP ₹5.62
MoS: -202.2% (Negative)Confidence: 59/100 (Moderate)Models: 1 Fair, 7 Over
ModelCategoryValueWeightSignal
PE-ROEEarnings₹5.9625%Fair (+6%)
Graham NumberEarnings₹0.7818%Over (-86.1%)
Earnings PowerEarnings₹0.1612%Over (-97.2%)
DCFCash Flow₹0.2615%Over (-95.4%)
Net Asset ValueAssets₹1.348%Over (-76.2%)
Earnings YieldEarnings₹0.208%Over (-96.4%)
ROCE CapitalReturns₹0.548%Over (-90.4%)
Revenue MultipleRevenue₹0.136%Over (-97.7%)
Consensus (8 models)₹1.86100%Overvalued
Key Drivers: P/E of 308 makes PE-ROE unreliable — asset/earnings models are better benchmarks. | ROE 1.8% is below cost of equity.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 0.0%

*Investments are subject to market risks

Investment Snapshot

48
Achyut Healthcare Ltd scores 48/100 (Average)
Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison
Stock Health62/100 · Moderate
ROCE 2.3% WeakROE 1.8% WeakD/E 0.00 Low debtInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent
Smart Money40/100 · Moderate
FII holding down -2.89% (6mo) SellingPromoter increased by 0.64% Positive
Earnings Quality55/100 · Moderate
OPM expanding (-5% → -3%) ImprovingWorking capital: 1,169 days Capital intensive
Quarterly Momentum50/100 · Moderate
Industry Rank10/100 · Weak
P/E 308.0 vs industry 53.8 Premium to peersROCE 2.3% vs industry 16.4% Below peersROE 1.8% vs industry 15.2% Below peers3Y sales CAGR: -9% Shrinking

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 3:59 am

Market Cap 132 Cr.
Current Price 5.62
Intrinsic Value₹1.86
High / Low 6.80/3.00
Stock P/E308
Book Value 1.34
Dividend Yield0.00 %
ROCE2.26 %
ROE1.77 %
Face Value 1.00
PEG Ratio0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Achyut Healthcare Ltd

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Achyut Healthcare Ltd 132 Cr. 5.62 6.80/3.00308 1.340.00 %2.26 %1.77 % 1.00
Brooks Laboratories Ltd 131 Cr. 44.5 166/36.36.07 39.30.00 %9.93 %12.2 % 10.0
Coral Laboratories Ltd 137 Cr. 383 785/3609.57 5960.39 %17.4 %13.1 % 10.0
Gujarat Inject (Kerala) Ltd 120 Cr. 82.1 82.1/17.0481 6.930.00 %13.5 %11.0 % 10.0
Aarey Drugs & Pharmaceuticals Ltd 151 Cr. 53.3 100/41.144.0 52.50.00 %6.38 %2.96 % 10.0
Industry Average19,815.15 Cr1,053.8453.84201.200.39%16.35%15.16%6.10

All Competitor Stocks of Achyut Healthcare Ltd

Quarterly Result

MetricDec 2024Sep 2025Dec 2025
Sales 0.002.551.57
Expenses 0.132.471.58
Operating Profit -0.130.08-0.01
OPM % 3.14%-0.64%
Other Income 0.180.110.04
Interest 0.000.000.00
Depreciation 0.000.030.03
Profit before tax 0.050.160.00
Tax % 20.00%31.25%
Net Profit 0.030.120.00
EPS in Rs 0.000.010.00

Last Updated: February 3, 2026, 11:16 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 26, 2026, 2:46 pm

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Sales 0.670.330.274.052.706.143.05
Expenses 0.660.320.264.082.976.123.25
Operating Profit 0.010.010.01-0.03-0.270.02-0.20
OPM % 1.49%3.03%3.70%-0.74%-10.00%0.33%-6.56%
Other Income 0.000.010.000.140.590.730.92
Interest 0.000.000.000.000.000.000.00
Depreciation 0.000.000.000.010.010.010.02
Profit before tax 0.010.020.010.100.310.740.70
Tax % 300.00%0.00%0.00%60.00%25.81%32.43%22.86%
Net Profit -0.010.010.010.040.230.500.55
EPS in Rs -0.020.020.020.000.010.020.02
Dividend Payout % 0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2019-20202020-20212021-20222022-20232023-20242024-2025
YoY Net Profit Growth (%)200.00%0.00%300.00%475.00%117.39%10.00%
Change in YoY Net Profit Growth (%)0.00%-200.00%300.00%175.00%-357.61%-107.39%

Achyut Healthcare Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2019-2020 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:%
5 Years:56%
3 Years:-9%
TTM:-50%
Compounded Profit Growth
10 Years:%
5 Years:123%
3 Years:140%
TTM:-4%
Stock Price CAGR
10 Years:%
5 Years:%
3 Years:88%
1 Year:44%
Return on Equity
10 Years:%
5 Years:2%
3 Years:2%
Last Year:2%

Last Updated: September 5, 2025, 2:01 pm

Balance Sheet

Last Updated: December 10, 2025, 3:43 am

MonthMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital 0.250.250.256.749.3516.8323.5623.56
Reserves -0.05-0.040.002.345.1813.937.747.98
Borrowings 0.000.000.000.000.000.000.000.00
Other Liabilities 0.040.060.250.860.810.191.292.48
Total Liabilities 0.240.270.509.9415.3430.9532.5934.02
Fixed Assets 0.000.000.000.030.050.060.030.26
CWIP 0.000.000.000.003.499.1618.1924.38
Investments 0.000.000.001.701.300.000.000.00
Other Assets 0.240.270.508.2110.5021.7314.379.38
Total Assets 0.240.270.509.9415.3430.9532.5934.02

Reserves and Borrowings Chart

Cash Flow

MonthMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity + -0.03-0.020.01-6.96-0.43-0.36-4.06
Cash from Investing Activity + 0.000.000.00-1.60-4.81-15.234.69
Cash from Financing Activity + 0.000.000.008.795.2115.720.00
Net Cash Flow -0.03-0.020.010.24-0.030.140.62
Free Cash Flow -0.03-0.020.01-6.99-3.75-6.37-14.92
CFO/OP -300%-100%100%23,100%126%-700%1,945%

Free Cash Flow

MonthMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Free Cash Flow0.010.010.01-0.03-0.270.02-0.20

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 54.48188.03378.5218.0236.5024.37160.36
Inventory Days 0.000.00158.7014.2959.593.9624.16
Days Payable 380.8741.7855.8712.54143.71
Cash Conversion Cycle 54.48188.03156.34-9.4640.2215.7940.81
Working Capital Days 76.27210.15216.30603.831,257.221,242.431,169.20
ROCE %9.76%4.35%2.14%2.63%3.27%2.26%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2022Sep 2022Mar 2023Apr 2023Sep 2023Mar 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Promoters 66.18%66.18%53.77%53.77%53.77%44.80%46.11%46.11%46.11%46.37%47.07%47.71%
FIIs 0.00%0.00%0.00%0.00%0.00%0.00%6.14%8.15%8.15%6.14%5.26%5.26%
Public 33.82%33.82%46.22%46.22%46.24%55.20%47.76%45.75%45.75%47.49%47.67%47.02%
No. of Shareholders 245155158162167179193471524541565514

Shareholding Pattern Chart

No. of Shareholders

Achyut Healthcare Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 1.0010.0010.0010.0010.00
Basic EPS (Rs.) 0.020.340.310.150.30
Diluted EPS (Rs.) 0.020.340.310.150.30
Cash EPS (Rs.) 0.020.340.250.060.29
Book Value[Excl.RevalReserv]/Share (Rs.) 1.3318.2815.5413.488.68
Book Value[Incl.RevalReserv]/Share (Rs.) 1.3318.2815.5413.488.68
Revenue From Operations / Share (Rs.) 0.123.652.886.0110.91
PBDIT / Share (Rs.) 0.030.440.330.150.42
PBIT / Share (Rs.) 0.020.440.330.150.42
PBT / Share (Rs.) 0.020.440.330.140.40
Net Profit / Share (Rs.) 0.020.340.240.050.29
PBDIT Margin (%) 23.6012.2411.782.623.85
PBIT Margin (%) 23.0912.1111.542.493.85
PBT Margin (%) 23.0812.0711.482.483.74
Net Profit Margin (%) 17.979.348.570.992.71
Return on Networth / Equity (%) 1.741.861.590.443.41
Return on Capital Employeed (%) 2.242.412.141.114.83
Return On Assets (%) 1.681.851.500.401.57
Asset Turnover Ratio (%) 0.090.260.210.770.73
Current Ratio (X) 9.32106.6612.689.461.82
Quick Ratio (X) 9.18106.3812.299.311.44
Inventory Turnover Ratio (X) 25.090.000.000.000.00
Interest Coverage Ratio (X) 3596.50375.85186.88169.5435.00
Interest Coverage Ratio (Post Tax) (X) 2739.50287.60137.0065.1425.67
Enterprise Value (Cr.) 75.7987.1050.8613.590.00
EV / Net Operating Revenue (X) 24.8714.1918.873.360.00
EV / EBITDA (X) 105.37115.87160.10127.690.00
MarketCap / Net Operating Revenue (X) 25.2014.2518.963.420.00
Price / BV (X) 2.452.843.521.520.00
Price / Net Operating Revenue (X) 25.2114.2618.963.420.00
EarningsYield 0.010.010.000.000.00

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Achyut Healthcare Ltd. is a Public Limited Listed company incorporated on 11/01/1996 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L67120GJ1996PLC028600 and registration number is 028600. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 3.05 Cr. and Equity Capital is Rs. 23.56 Cr. for the Year ended 31/03/2025.
INDUSTRYADDRESSCONTACT
Pharmaceuticals610, Colonade, B/H Iscon Temple, Opposite Iscon, BRTS Bus Stand, Ahmedabad Gujarat 380058Contact not found
Management
NamePosition Held
Mr. Mahendra C RaychaChairman & Non-Exe.Director
Mr. Jigen J ModiManaging Director
Ms. Amisha J ModiExecutive Director
Mr. Akshit RaychaNon Executive Director
Mr. Rutvik S ThakkarIndependent Director
Mrs. Sonu L JainIndependent Director
Mr. Paragkumar S DaveIndependent Director
Mr. Rajesh C SutariaIndependent Director

FAQ

What is the intrinsic value of Achyut Healthcare Ltd and is it undervalued?

As of 07 April 2026, Achyut Healthcare Ltd's intrinsic value is ₹1.86, which is 66.90% lower than the current market price of ₹5.62, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (1.77 %), book value (₹1.34), dividend yield (0.00 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Achyut Healthcare Ltd?

Achyut Healthcare Ltd is trading at ₹5.62 as of 07 April 2026, with a FY2026-2027 high of ₹6.80 and low of ₹3.00. The stock is currently in the middle of its 52-week range. Market cap stands at ₹132 Cr..

How does Achyut Healthcare Ltd's P/E ratio compare to its industry?

Achyut Healthcare Ltd has a P/E ratio of 308, which is above the industry average of 53.84. This significantly elevated P/E suggests the market expects strong future growth, or the stock may be overpriced relative to current earnings.

Is Achyut Healthcare Ltd financially healthy?

Key indicators for Achyut Healthcare Ltd: ROCE of 2.26 % is on the lower side compared to the industry average of 16.35%; ROE of 1.77 % is below ideal levels (industry average: 15.16%). Dividend yield is 0.00 %.

Is Achyut Healthcare Ltd profitable and how is the profit trend?

Achyut Healthcare Ltd reported a net profit of ₹1 Cr in Mar 2025 on revenue of ₹3 Cr. Compared to ₹0 Cr in Mar 2022, the net profit shows an improving trend.

Does Achyut Healthcare Ltd pay dividends?

Achyut Healthcare Ltd has a dividend yield of 0.00 % at the current price of ₹5.62. The company is currently not paying meaningful dividends.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Achyut Healthcare Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
Explore Industry-wise Stock Analysis Reports